[go: up one dir, main page]

Lee, 1999 - Google Patents

Ask the doctor. I have diabetes and use insulin two, sometimes three, times a day to keep my sugar under control. My hope is that this will help me avoid a heart attack …

Lee, 1999

Document ID
10942811773317045081
Author
Lee T
Publication year
Publication venue
Harvard heart letter: from Harvard Medical School

External Links

Continue reading at pubmed.ncbi.nlm.nih.gov (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents

Similar Documents

Publication Publication Date Title
HK1045655A1 (en) Pharmaceutical composition comprising a combination of metformin and glibenclamide
WO2001032157A3 (en) Pharmaceutical composition comprising a combination of metformin and glibenclamide
WO2003089033A8 (en) Implantable drug delivery system responsive to intra-cardiac pressure
CA2332368A1 (en) A medical apparatus for use by a patient for medical self treatment of diabetes
IL166571A0 (en) Medical treatment system by substituting native biological regulatory function: cardiac pacing system blood pressure regulating system and cardiac disease treatment system based on the medical system
US6056729A (en) Ornamental article for transdermal drug delivery
Berstad Today's therapy of functional gastrointestinal disorders--does it help?
Lee Ask the doctor. I have diabetes and use insulin two, sometimes three, times a day to keep my sugar under control. My hope is that this will help me avoid a heart attack. Is this a reasonable goal?
Nielsen et al. Prevalence of macro-and microvascular disease as related to glycosylated hemoglobin in type I and II diabetic subjects. An epidemiologic study in Denmark
CA2091134A1 (en) Therapeutic agent for threatened abortion
CA2374269A1 (en) Stimulating transport of glucose into animal tissue by the administration of pinitol
Pena et al. Severe hemolytic uremic syndrome associated with rhabdomyolysis and insulin-dependent diabetes mellitus
RU2004103531A (en) PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING SIMULTANEOUS METFORMIN AND GLYCLAZIDE
Holmwood et al. Insulin and type 2 diabetes. Last resort or rational management?
WO2003082283A3 (en) Pharmaceutical composition with combined active agents and methods for using the same
AU4633197A (en) Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid
Fetkovska et al. Long-term clinical experience with guanfacine
James ddI: FDA approves once-daily dosing. Food and Drug Administration
Papazafiropoulou et al. Diabetes drugs and cardiovascular safety
Aman et al. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus
Simon I am a 46-year-old man with hypertension. I recently started taking Inderal for my blood pressure. I feel fine and my pressure is way down, but I can no longer get my pulse up when I work out on my treadmill or bike. Does that mean I won't benefit from exercise anymore?
Wakelee-Lynch Interferon may offer first drug therapy for diabetic retinopathy. New research showing that alpha-interferon blocks new blood vessel formation in the iris of monkeys may point the way to new treatment for diabetes retinopathy
RU2001111623A (en) METHOD FOR TREATING PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH SISTOLIC LEFT VENTRICULAR DYSFUNCTION
Ebeling et al. Comments to: Yudkin J, Panahloo A, Stenhouwer C et al.(2000) the influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in type II diabetic subjects. Diabetologia 43: 1099-1106
Fujimoto Therapeutic utility of biguanides in the treatment of NIDDM